Annalisa Trama

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. doi request reprint The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project
    Annalisa Trama
    Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Tumori 98:550-8. 2012
  2. doi request reprint Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
    A Trama
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:159-69. 2012
  3. doi request reprint Quality of life in clinical trials for children
    Annalisa Trama
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Clin Pharmacol 67:41-7. 2011
  4. doi request reprint The burden of rare cancers in Europe
    Gemma Gatta
    Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
    Adv Exp Med Biol 686:285-303. 2010
  5. doi request reprint Rare cancers are not so rare: the rare cancer burden in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 47:2493-511. 2011
  6. doi request reprint Embryonal cancers in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:1425-33. 2012
  7. doi request reprint Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization
    Gemma Gatta
    Evaluative Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    J Natl Cancer Inst Monogr 2013:79-87. 2013
  8. pmc Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
    Haematologica 98:744-52. 2013
  9. doi request reprint Thymoma and thymic carcinomas
    Marta Scorsetti
    Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
    Crit Rev Oncol Hematol 99:332-50. 2016
  10. doi request reprint Diagnosis and management of typical and atypical lung carcinoids
    Sara Pusceddu
    Medical Oncology Department, Fondazione IRCCS Istituto Nazionale di Tumori, Via G Venezian 1, 20133 Milan, Italy
    Crit Rev Oncol Hematol 100:167-76. 2016

Detail Information

Publications10

  1. doi request reprint The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project
    Annalisa Trama
    Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Tumori 98:550-8. 2012
    ....
  2. doi request reprint Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
    A Trama
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:159-69. 2012
    ..Considering the high prevalence of these highly curable cancers, it is important to monitor patients long-term, so as to quantify treatment-related risks and develop treatments having limited impact on quality of life...
  3. doi request reprint Quality of life in clinical trials for children
    Annalisa Trama
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Clin Pharmacol 67:41-7. 2011
    ....
  4. doi request reprint The burden of rare cancers in Europe
    Gemma Gatta
    Fondazione IRCCS Istituto Nazionale dei Tumori, Dipartimento di Medicina Predittiva e per la Prevenzione, Unità di Epidemiologia Valutativa, Via Venezian, 1, 20133, Milan, Italy
    Adv Exp Med Biol 686:285-303. 2010
    ..The burden indicators were estimated and are provided in this chapter...
  5. doi request reprint Rare cancers are not so rare: the rare cancer burden in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 47:2493-511. 2011
    ..The project Surveillance of Rare Cancers in Europe (RARECARE) provides estimates of the incidence, prevalence and survival of rare cancers in Europe based on a new and comprehensive list of these diseases...
  6. doi request reprint Embryonal cancers in Europe
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Eur J Cancer 48:1425-33. 2012
    ..Survival/cure rate is generally high, but there are considerable gaps in our understanding of the natural histories of these rare diseases particularly in adults...
  7. doi request reprint Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization
    Gemma Gatta
    Evaluative Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    J Natl Cancer Inst Monogr 2013:79-87. 2013
    ..The treatments given for major cancers also varied; advanced stage at diagnosis was associated with poor 5-year relative survival and low odds of receiving standard treatment for breast and colorectal cancer. ..
  8. pmc Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002
    Gemma Gatta
    Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
    Haematologica 98:744-52. 2013
    ..Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries...
  9. doi request reprint Thymoma and thymic carcinomas
    Marta Scorsetti
    Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
    Crit Rev Oncol Hematol 99:332-50. 2016
    ..Since molecular aberrations are poorly understood and few responses are reported, targeted therapies are yet being studied. In this review, we describe key aspects of clinical management for Ts and TCs. ..
  10. doi request reprint Diagnosis and management of typical and atypical lung carcinoids
    Sara Pusceddu
    Medical Oncology Department, Fondazione IRCCS Istituto Nazionale di Tumori, Via G Venezian 1, 20133 Milan, Italy
    Crit Rev Oncol Hematol 100:167-76. 2016
    ..The aim of this review is to provide a useful guide for the clinical management of lung carcinoids. ..